LOGIN
Allogenic cancellous bone use in monosegmental spondylodesis
May 2013
Allogenic cancellous bone use in monosegmental spondylodesis
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Allogenic versus autologous cancellous bone in lumbar segmental spondylodesis: A randomized prospective study
Eur Spine J. 2009 May;18(5):687-95. Epub 2009 Jan 16Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
44 patients suffering monosegmental ventrodorsal spondylodesis were randomized to receive either autogenous corticocancellous iliac crest bone or allogenic cancellous bone for lumbar fusion, assessing the non-inferiority of the use of allogenic cancellous bone. The results from this study indicated that treatment with allogenic cancellous bone was equivalent to autogenous corticocancellous iliac c...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.